Month: June 2024

AD04 reduced heavy drinking days among heavy drinking individuals with alcohol use disorder and a specific genetic profile, as identified by a companion diagnostic test (CDx) GLEN ALLEN, Va., June 20, 2024 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, announced the publication of previously disclosed results from its Phase 3 ONWARD study in a peer-reviewed article in the European Journal of Internal Medicine entitled, “Low-dose ondansetron: A candidate prospective precision medicine to treat alcohol use disorder endophenotypes.” The publication findings showed a significant difference in the monthly percentage of heavy drinking days between the...

FAIRFIELD, N.J., June 20, 2024 (GLOBE NEWSWIRE) — Kearny Financial Corp. (NASDAQ GS: KRNY) (the “Company”), the holding company for Kearny Bank (the “Bank”), announced today that the Board of Directors promoted Keith Suchodolski to Senior Executive Vice President and Chief Operating Officer, effective July 1, 2024. Mr. Suchodolski has held progressive leadership roles within the Company since 2013, most recently serving as Chief Financial Officer since July 2018. In his new role, Mr. Suchodolski’s range of responsibilities will broaden to include strategic oversight of retail & business banking, human resources, marketing, corporate finance and corporate administration. Craig L. Montanaro, President and Chief Executive Officer said, “Keith is an accomplished leader with a track record of success throughout his time with the...

Following FDA Approval to Commence the Clinical Trial, an Official Site Initiation Has Taken Place as Preparation for Patient Enrollment Advances Multiple Robotic Systems Already Received by the Site to Allow Inventory Readiness in Support of Trial BRAINTREE, Mass., June 20, 2024 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT) announced its agreement with Brigham and Women’s Hospital (BWH), a leading academic medical center located in Boston, Massachusetts, to serve as one of the sites to perform the pivotal human clinical trial for its LIBERTY® Endovascular Robotic Surgical System, as part of its Investigational Device Exemption (“IDE”) application. This development, previously announced on June 17, 2024, follows the U.S. Food and Drug Administration’s approval to commence Microbot’s pivotal human clinical trial. The Company...

Minneapolis, MN, June 20, 2024 (GLOBE NEWSWIRE) — Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // Purpose-driven digital payment platform, Sezzle, today announced that the Company’s Board of Directors (the “Board”) has authorized the repurchase of an additional $15.0 million of the Company’s common stock after completing its $5.0 million stock repurchase plan announced on December 22, 2023. The manner, timing and amount of any purchase will be based on an evaluation of market conditions, stock price and other factors. “Our confidence in the Company’s continued momentum allows the Board to authorize a new $15 million stock repurchase program,” stated Charlie Youakim, Sezzle Chairman and CEO. “We remain committed to maximizing shareholder value through a disciplined capital allocation policy that will drive growth and maintain...

TORONTO, June 20, 2024 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, announced an expansion of Cronos Growing Company (“GrowCo”). GrowCo is a leading cannabis cultivation company that Cronos owns 50% of. The investment will be funded by an additional credit facility provided by Cronos and is intended to assist GrowCo’s expansion of its purpose-built cannabis facility to address the increased global market demand for high-quality cannabis flower. Key Highlights of the Investment:Investment in Expansion: Cronos will provide an approximately $51 million ($70 million CAD) secured non-revolving credit facility to GrowCo to fund facility expansion, enabling growth opportunities in the markets Cronos operates in today as well as enabling future...

Revolutionizing Power Solutions with Exceptional Longevity, Efficiency, and Compatibility JINHUA, CHINA, June 20, 2024 (GLOBE NEWSWIRE) — Kandi Technologies Group, Inc. (NASDAQ GS: KNDI) (“Kandi” or the “Company”), a leader in all-electric personal transportation and utility vehicles and a pioneer in battery technology innovation and manufacturing, today announced the launch of its new AA battery, now available for sale in the United States. Designed to meet the growing demand for reliable and long-lasting power solutions, Kandi’s AA battery offers unparalleled energy capacity, quick charging capabilities, and wide device compatibility. With an impressive 2700 mWh energy capacity, 1500 recharging cycles, and minimal power loss, these batteries are engineered to last, saving consumers money and reducing waste. The quick and...

Top American auto racing team taps ABM’s EV charging solutions to power ambitions for record-breaking runCOLORADO SPRINGS, Colo., June 20, 2024 (GLOBE NEWSWIRE) — Bryan Herta Autosport (“BHA”) will drive Hyundai IONIQ 5 N TA Spec and production vehicles as part of an all-electric effort at the 102nd running of the Pikes Peak International Hill Climb in Colorado Springs, CO, and is partnering with electric vehicle (“EV”) charging solutions leader ABM (NYSE: ABM) for on-site fast charging. BHA is targeting Electric Production SUV/Crossover and Electric Modified SUV/Crossover records at the legendary course. At the Pikes Peak International Hill Climb, the BHA team will drive a Hyundai IONIQ 5 N and two Hyundai IONIQ 5 N TA Spec vehicles for the ascent along a grueling 12.42-mile course that climbs over 4,700 feet to the 14,115-foot-high...

Joint Marketing Effort and Deep Technical Integration Unlocks New Capabilities, Giving Brands New Ways to Increase Traffic, Engagement, and Loyalty Program Utilization PHOENIX and NEWTON, Mass., June 20, 2024 (GLOBE NEWSWIRE) — Mobivity Holdings Corp. (OTCQB: MFON), a provider of technology connecting mobile gaming audiences to real-world brands and offers, announced today a strategic partnership and technical integration with Paytronix, the leading provider of loyalty and guest engagement solutions. This partnership expands capabilities for Paytronix customers, giving their vast network of brick-and-mortar brands new ways to increase loyalty program utilization and drive higher engagement of current and lapsed customers through Connected Rewards programs. Once connected, users will seamlessly receive loyalty points for downloading...

Additional presentation will further characterize the potential impact of bezisterim on motor and specific non-motor symptoms of Parkinson’s disease CARSON CITY, Nev., June 20, 2024 (GLOBE NEWSWIRE) — BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today announced two poster presentations at the Advanced Therapeutics in Movement and Related Disorders Congress® (ATMRD Congress) being held June 21-25, 2024 in Washington, D.C. The presentation Assessment of Bezisterim (NE3107) in Patients with Early Parkinson’s Disease: A Phase 2, Placebo-Controlled Study will outline the study protocol of the Company’s upcoming Phase 2 trial evaluating bezisterim people with Parkinson’s...